KaydedilenlerDerginizi ekleyin

Dergiler / Black Sea Journal of Health Science / 2026 / Cilt: 9 Sayı: 3

Associations of Neurogenic Bladder Symptom Score with King’s Health Questionnaire and Bladder Diary Parameters in Female Patients with Multiple Sclerosis: Cross-Sectional Research

Büşra Aydın Erkılıç(MARMARA ÜNİVERSİTESİ)0000-0001-8702-829X
Semra Oğuz(MARMARA ÜNİVERSİTESİ)0000-0002-7148-4562
Elif Unal(UNIVERSITY OF HEALTH SCIENCES, İSTANBUL OKMEYDANI HEALTH RESEARCH CENTER, DEPARTMENT OF INTERNAL MEDICINE, DEPARTMENT OF NEUROLOGY)0000-0002-6830-1788
Canan Emir(UNIVERSITY OF HEALTH SCIENCES, İSTANBUL OKMEYDANI HEALTH RESEARCH CENTER, DEPARTMENT OF INTERNAL MEDICINE, DEPARTMENT OF NEUROLOGY)0000-0002-5418-930X
Sayfa
97–103
Yayın Tarihi
2026-05-15
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Larger prospective studies involving both genders and a broader spectrum of the multiple sclerosis population are needed to confirm these findings.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:This study aimed to determine whether the Neurogenic Bladder Symptom Score could be effectively associated with bladder diaries and the King's Health Questionnaire in evaluating lower urinary tract symptoms and associated quality of life among female patients with multiple sclerosis.
📊
Temel Bulgular & Veri:Neurogenic Bladder Symptom Score incontinence and quality of life domains showed moderate correlations with bladder diary urgency/incontinence and several King's Health Questionnaire subscales (r=0.33–0.57, P<0.05).
💡
Sonuç & Katkı:Larger prospective studies involving both genders and a broader spectrum of the multiple sclerosis population are needed to confirm these findings.
🔬Tür:Uygulamalı Anket & Alan Araştırması
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Multiple sclerosis · Neurogenic bladder · Quality of life

Özet

This study aimed to determine whether the Neurogenic Bladder Symptom Score could be effectively associated with bladder diaries and the King's Health Questionnaire in evaluating lower urinary tract symptoms and associated quality of life among female patients with multiple sclerosis. Forty female multiple sclerosis patients who were screened and met the inclusion criteria participated in this cross-sectional study. They filled out the King's Health Questionnaire, completed the Neurogenic Bladder Symptom Score, and kept a bladder diary for three days. The Neurogenic Bladder Symptom Score domains (incontinence, storage/voiding, consequences, quality of life), bladder diary data, and King's Health Questionnaire subscales were compared using Pearson correlation analysis. Neurogenic Bladder Symptom Score incontinence and quality of life domains showed moderate correlations with bladder diary urgency/incontinence and several King's Health Questionnaire subscales (r=0.33–0.57, P<0.05). Neurogenic Bladder Symptom Score total scores also correlated moderately with bladder diary incontinence and specific subscales of King's Health Questionnaire (r=0.35–0.58, P<0.05). The moderate correlations observed suggest that the Neurogenic Bladder Symptom Score is significantly associated with specific clinical findings from bladder diaries and quality of life assessments. These results indicate that the Neurogenic Bladder Symptom Score has the potential to partially reflect certain aspects of symptom burden and urinary-specific quality of life in female patients with multiple sclerosis. Larger prospective studies involving both genders and a broader spectrum of the multiple sclerosis population are needed to confirm these findings.

Abstract

This study aimed to determine whether the Neurogenic Bladder Symptom Score could be effectively associated with bladder diaries and the King's Health Questionnaire in evaluating lower urinary tract symptoms and associated quality of life among female patients with multiple sclerosis. Forty female multiple sclerosis patients who were screened and met the inclusion criteria participated in this cross-sectional study. They filled out the King's Health Questionnaire, completed the Neurogenic Bladder Symptom Score, and kept a bladder diary for three days. The Neurogenic Bladder Symptom Score domains (incontinence, storage/voiding, consequences, quality of life), bladder diary data, and King's Health Questionnaire subscales were compared using Pearson correlation analysis. Neurogenic Bladder Symptom Score incontinence and quality of life domains showed moderate correlations with bladder diary urgency/incontinence and several King's Health Questionnaire subscales (r=0.33–0.57, P<0.05). Neurogenic Bladder Symptom Score total scores also correlated moderately with bladder diary incontinence and specific subscales of King's Health Questionnaire (r=0.35–0.58, P<0.05). The moderate correlations observed suggest that the Neurogenic Bladder Symptom Score is significantly associated with specific clinical findings from bladder diaries and quality of life assessments. These results indicate that the Neurogenic Bladder Symptom Score has the potential to partially reflect certain aspects of symptom burden and urinary-specific quality of life in female patients with multiple sclerosis. Larger prospective studies involving both genders and a broader spectrum of the multiple sclerosis population are needed to confirm these findings.

🔖

Bu Makaleye Atıf Yap

Erkılıç, B. A., Oğuz, S., Unal, E., Emir, C. (2026). Associations of Neurogenic Bladder Symptom Score with King’s Health Questionnaire and Bladder Diary Parameters in Female Patients with Multiple Sclerosis: Cross-Sectional Research. Black Sea Journal of Health Science, Cilt: 9 Sayı: 3, 97–103. https://doi.org/10.19127/bshealthscience.1868613

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (26)

  1. Akkoc, Y., Karapolat, H., Eyigor, S., Yesil, H., & Yuceyar, N. (2011). Quality of life in multiple sclerosis patients with urinary disorders: reliability and validity of the Turkish version of King's Health Questionnaire. Neurological Sciences, 32(3), 417-421. https://doi.org/10.1007/s10072-011-0484-9
  2. Al Dandan, H. B., Coote, S., & McClurg, D. (2020). Prevalence of lower urinary tract symptoms in people with multiple sclerosis: a systematic review and meta-analysis. International Journal of MS Care, 22(2), 91-99. https://doi.org/10.7224/1537-2073.2019-030
  3. Beck, J., Jaekel, A. K., Zeller, F. L., Kowollik, M., Kurze, I., Kaufmann, A., Feneberg, W., Brandt, A., Flachenecker, P., Henze, T., Domurath, B., Schmidt, P., Vance, W. N., Goldschmidt, F., Kirschner-Hermanns, R. K. M., & Knupfer, S. C. (2022). Clinical predictors of neurogenic lower urinary tract dysfunction in persons with multiple sclerosis. Diagnostics, 12(1). https://doi.org/10.3390/diagnostics12010191
  4. Büyüköztürk, Ş. (2018). Sosyal bilimler için veri analizi el kitabı. Pegem Akademi.
  5. Çapık, C. (2014). İstatistiksel güç analizi ve hemşirelik araştırmalarında kullanımı: temel bilgiler. Journal of Anatolia Nursing and Health Sciences, 17(4), 268-274.
  6. de Seze, M., Ruffion, A., Denys, P., Joseph, P. A., Perrouin-Verbe, B., & Genulf. (2007). The neurogenic bladder in multiple sclerosis: review of the literature and proposal of management guidelines. Multiple Sclerosis Journal, 13(7), 915-928. https://doi.org/10.1177/1352458506075651
  7. Filippi, M., Bar-Or, A., Piehl, F., Preziosa, P., Solari, A., Vukusic, S., & Rocca, M. A. (2018). Multiple sclerosis. Nature Reviews Disease Primers, 4(1), 43. https://doi.org/10.1038/s41572-018-0041-4
  8. Fragala, E., Russo, G. I., Di Rosa, A., Giardina, R., Privitera, S., Favilla, V., Patti, F., Welk, B., Cimino, S., Castelli, T., & Morgia, G. (2015). Association between the neurogenic bladder symptom score and urodynamic examination in multiple sclerosis patients with lower urinary tract dysfunction. International Neurourology Journal, 19(4), 272-277. https://doi.org/10.5213/inj.2015.19.4.272
  9. Guler, M. A., Dogan, D., & Yilmaz Yalcinkaya, E. (2022). Validity and reliability of the Turkish version of the neurogenic bladder symptom score. Disability and Rehabilitation, 44(12), 2889-2895. https://doi.org/10.1080/09638288.2020.1846216
  10. Haegel, A., Grasland, M., Robert, H., & Pichon, B. (2025). Bladder diary feasibility and reliability in neurogenic lower urinary tract dysfunction patients. Neurourology Urodynamics, 44(5), 1120-1125. https://doi.org/10.1002/nau.70063
  11. Karapolat, H., Akkoc, Y., Eyigor, S., & Tanigor, G. (2018). Bladder-related quality of life in people with neurological disorders: reliability and validity of the Turkish version of the King's Health Questionnaire in people with spinal cord injury. Turkish Journal of Urology, 44(5), 411-417. https://doi.org/10.5152/tud.2018.45556
  12. Kelleher, C. J., Cardozo, L. D., Khullar, V., & Salvatore, S. (1997). A new questionnaire to assess the quality of life of urinary incontinent women. BJOG: An International Journal of Obstetrics & Gynaecology, 104(12), 1374-1379. https://doi.org/10.1111/j.1471-0528.1997.tb11006.x
  13. Khalaf, K. M., Coyne, K. S., Globe, D. R., Malone, D. C., Armstrong, E. P., Patel, V., & Burks, J. (2016). The impact of lower urinary tract symptoms on health-related quality of life among patients with multiple sclerosis. Neurourology Urodynamics, 35(1), 48-54. https://doi.org/10.1002/nau.22670
  14. Nambiar, A. K., Arlandis, S., Bo, K., Cobussen-Boekhorst, H., Costantini, E., de Heide, M., Farag, F., Groen, J., Karavitakis, M., Lapitan, M. C., Manso, M., Arteaga, S. M., Riogh, A. N. A., O'Connor, E., Omar, M. I., Peyronnet, B., Phe, V., Sakalis, V. I., Sihra, N.,…Harding, C. K. (2022). European Association of Urology Guidelines on the diagnosis and management of female non-neurogenic lower urinary tract symptoms. Part 1: Diagnostics, overactive bladder, stress urinary incontinence, and mixed urinary incontinence. European Urology, 82(1), 49-59. https://doi.org/10.1016/j.eururo.2022.01.045
  15. Nambiar, A., & Lucas, M. (2014). Chapter 4: Guidelines for the diagnosis and treatment of overactive bladder (OAB) and neurogenic detrusor overactivity (NDO). Neurourology Urodynamics, 33(Suppl 3), S21-25. https://doi.org/10.1002/nau.22631
  16. Phe, V., Chartier-Kastler, E., & Panicker, J. N. (2016). Management of neurogenic bladder in patients with multiple sclerosis. Nature Reviews Urology, 13(5), 275-288. https://doi.org/10.1038/nrurol.2016.53
  17. Philippova, E. S., Bazhenov, I. V., Volkova, L. I., Moskvina, E. Y., Turova, E. L., & Popova, Y. V. (2018). Russian version of the neurogenic bladder symptom score (NBSS). Urologiia, 6(5), 5-13.
  18. Polman, C. H., Reingold, S. C., Banwell, B., Clanet, M., Cohen, J. A., Filippi, M., Fujihara, K., Havrdova, E., Hutchinson, M., Kappos, L., Lublin, F. D., Montalban, X., O'Connor, P., Sandberg-Wollheim, M., Thompson, A. J., Waubant, E., Weinshenker, B., & Wolinsky, J. S. (2011). Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Annals of Neurology, 69(2), 292-302. https://doi.org/10.1002/ana.22366
  19. Schober, P., Boer, C., & Schwarte, L. A. (2018). Correlation Coefficients: Appropriate Use and Interpretation. Anesthesia & Analgesia, 126(5), 1763-1768. https://doi.org/10.1213/ane.0000000000002864
  20. Shrivastava, N., Sarangi, S. S., Tripathi, S., Bhargava, P., Bhirud, D. P., & Jena, R. (2023). Bladder diary for illiterates: A novel method. Urologia Journal, 90(4), 748-756. https://doi.org/10.1177/03915603231187684
  21. Tudor, K. I., Bosnjak Pasic, M., Nad Skegro, S., Bakula, M., Nemir, J., Mustac, F., Vidrih, B., Pasic, H., Vujevic, L., Rajic, F., & Tudor Car, L. (2020). Lower Urinary Tract Symptoms and Depression in Patients with Multiple Sclerosis. Psychiatr Danub, 32(Suppl 4), 511-519. https://www.ncbi.nlm.nih.gov/pubmed/33212457
  22. Walawska-Hrycek, A., Dudek, M., Fura, T., Silldorff, J., & Siuda, J. (2024). The impact of bladder symptoms on Relapsing Remitting Multiple Sclerosis patients' Quality of Life - a pilot study. Wiadomości Lekarskie Medical Advances, 77(11), 2326-2331. https://doi.org/10.36740/WLek/195752
  23. Welk, B., Lenherr, S., Elliott, S., Stoffel, J., Gomes, C. M., de Bessa, J., Cintra, L. K. L., Myers, J. B., & Neurogenic Bladder Research, G. (2020). The creation and validation of a short form of the Neurogenic Bladder Symptom Score. Neurourology Urodynamics, 39(4), 1162-1169. https://doi.org/10.1002/nau.24336
  24. Welk, B., Lenherr, S., Elliott, S., Stoffel, J., Presson, A. P., Zhang, C., & Myers, J. B. (2018). The Neurogenic Bladder Symptom Score (NBSS): a secondary assessment of its validity, reliability among people with a spinal cord injury. Spinal Cord, 56(3), 259-264. https://doi.org/10.1038/s41393-017-0028-0
  25. Welk, B., Morrow, S., Madarasz, W., Baverstock, R., Macnab, J., & Sequeira, K. (2014). The validity and reliability of the neurogenic bladder symptom score. Journal of Urology, 192(2), 452-457. https://doi.org/10.1016/j.juro.2014.01.027
  26. Zecca, C., Riccitelli, G. C., Disanto, G., Singh, A., Digesu, G. A., Panicari, L., Puccini, F., Mattioli, M., Tubaro, A., & Gobbi, C. (2016). Urinary incontinence in multiple sclerosis: prevalence, severity and impact on patients' quality of life. European Journal of Neurology, 23(7), 1228-1234. https://doi.org/10.1111/ene.13010